Home › Funds › ARIEL INVESTMENTS, LLC › BIO
ARIEL INVESTMENTS, LLC position in BIO
BIO RAD LABS INC · Industrials
ARIEL INVESTMENTS, LLC reported holding 789,341 shares of BIO (BIO RAD LABS INC) in its Q3 2026 13F filing — a position valued at US$298.1M, representing 3.10% of its reported portfolio and ranking #7 among its reported holdings. ARIEL INVESTMENTS, LLC has disclosed BIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How ARIEL INVESTMENTS, LLC's BIO position evolved
ARIEL INVESTMENTS, LLC first disclosed a stake in BIO in Q3 2023 at 4,529 shares (US$1.6M). The position peaked in Q3 2026 at 789,341 shares, worth US$298.1M. Across 13 filings, ARIEL INVESTMENTS, LLC increased the stake 8 time(s), trimmed it 4 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 789,341 shares valued at US$298.1M — a reduction of -27,410 shares quarter over quarter.. Notable position changes include a 1354% increase in Q1 2024 (shares fell 21% over the following quarter), a 60% increase in Q2 2024 (shares rose 23% over the following quarter), a 263% increase in Q3 2024 (shares fell 2% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 4.53K | $1.62M | New |
| Q4 2023 | 4.48K | $1.45M | Reduce |
| Q1 2024 | 65.09K | $22.51M | Add |
| Q2 2024 | 104.19K | $28.45M | Add |
| Q3 2024 | 378.69K | $126.70M | Add |
| Q4 2024 | 560.52K | $184.14M | Add |
| Q1 2025 | 724.66K | $176.50M | Add |
| Q2 2025 | 818.62K | $197.55M | Add |
| Q3 2025 | 809.48K | $226.97M | Reduce |
| Q4 2025 | 764.67K | $231.69M | Reduce |
| Q1 2026 | 785.96K | $219.09M | Add |
| Q2 2026 | 816.75K | $239.81M | Add |
| Q3 2026 | 789.34K | $298.14M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BIO and 13F data
BIO (BIO RAD LABS INC) is a Industrials company. 24 other funds we track also report a position in BIO — the largest reported positions include First Eagle Investment Management (US$927.5M), EARNEST PARTNERS LLC (US$214.5M), First Pacific Advisors, LP (US$101.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BIO
- First Eagle Investment Management 2.46M sh · $927.50M · Q3 2026
- EARNEST PARTNERS LLC 567.82K sh · $214.47M · Q3 2026
- First Pacific Advisors, LP 269.08K sh · $101.63M · Q3 2026
- NOMURA HOLDINGS INC 328.90K sh · $96.57M · Q2 2026
More on ARIEL INVESTMENTS, LLC
FAQ
How long has ARIEL INVESTMENTS, LLC held BIO?
ARIEL INVESTMENTS, LLC has disclosed BIO holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is ARIEL INVESTMENTS, LLC's current position in BIO?
As of Q3 2026, ARIEL INVESTMENTS, LLC holds 789.34K shares of BIO (BIO RAD LABS INC), valued at $298.14M, representing 3.10% of its reported portfolio and ranking #7.
Has ARIEL INVESTMENTS, LLC been buying or selling BIO?
In the latest 13F filing (Q3 2026), ARIEL INVESTMENTS, LLC reduced its position in BIO. The position peaked in Q3 2026 at 789.34K shares.
Which other funds hold BIO?
Other major institutional holders of BIO include First Eagle Investment Management, EARNEST PARTNERS LLC, First Pacific Advisors, LP, among 24 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.